Targeted therapy with phosphodiesterase 5 inhibitors in patients with pulmonary hypertension due to heart failure and elevated pulmonary vascular resistance: a systematic review

by Galo M. Sanchez Palacios, Cindy Schmidt, Tammy Wichman
Published 2020-09-01